Providing the TORC for cell cycle progression in neoplastic mast cells.
作者信息
Smrž Daniel, Wilson Todd M, Metcalfe Dean D, Gilfillan Alasdair M
出版信息
Cell Cycle. 2012 Jan 15;11(2):210-1. doi: 10.4161/cc.11.2.18976.
Abstract
摘要
相似文献
1
Providing the TORC for cell cycle progression in neoplastic mast cells.
Cell Cycle. 2012 Jan 15;11(2):210-1. doi: 10.4161/cc.11.2.18976.
2
mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells.
Blood. 2011 Dec 22;118(26):6803-13. doi: 10.1182/blood-2011-06-359984. Epub 2011 Nov 3.
3
Activation and function of the mTORC1 pathway in mast cells.
J Immunol. 2008 Apr 1;180(7):4586-95. doi: 10.4049/jimmunol.180.7.4586.
4
CELL GROWTH. (TORC)ing up purine biosynthesis.
Science. 2016 Feb 12;351(6274):670-1. doi: 10.1126/science.aaf1929.
5
Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release.
J Biol Chem. 2011 Jan 7;286(1):391-402. doi: 10.1074/jbc.M110.164772. Epub 2010 Oct 27.
6
Stem cells: The blood balance.
Nature. 2010 Dec 2;468(7324):644-5. doi: 10.1038/468644a.
7
Cell growth: RAC1 sizes up mTOR.
Nat Rev Mol Cell Biol. 2011 Jun;12(6):343. doi: 10.1038/nrm3124. Epub 2011 May 18.
8
Cell signalling: nutrient sensing lost in cancer.
Nature. 2013 Jun 27;498(7455):444-5. doi: 10.1038/498444a.
9
Regulation of mast cell survival and function by tuberous sclerosis complex 1.
Blood. 2012 Apr 5;119(14):3306-14. doi: 10.1182/blood-2011-05-353342. Epub 2012 Feb 23.
10
The integral role of mTOR in lipid metabolism.
Cell Cycle. 2011 Mar 15;10(6):861-2. doi: 10.4161/cc.10.6.14930.
本文引用的文献
1
mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells.
Blood. 2011 Dec 22;118(26):6803-13. doi: 10.1182/blood-2011-06-359984. Epub 2011 Nov 3.
2
Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release.
J Biol Chem. 2011 Jan 7;286(1):391-402. doi: 10.1074/jbc.M110.164772. Epub 2010 Oct 27.
3
Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood.
Curr Protoc Immunol. 2010 Aug;Chapter 7:Unit 7.37. doi: 10.1002/0471142735.im0737s90.
4
Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity.
Eur J Immunol. 2010 Jul;40(7):1843-51. doi: 10.1002/eji.201040559.
5
Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony.
J Biol Chem. 2010 May 7;285(19):14071-7. doi: 10.1074/jbc.R109.094003. Epub 2010 Mar 15.
6
Mast cells and mastocytosis.
Blood. 2008 Aug 15;112(4):946-56. doi: 10.1182/blood-2007-11-078097.
7
Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.
Br J Pharmacol. 2008 Aug;154(8):1572-82. doi: 10.1038/bjp.2008.204. Epub 2008 May 26.
8
Activation and function of the mTORC1 pathway in mast cells.
J Immunol. 2008 Apr 1;180(7):4586-95. doi: 10.4049/jimmunol.180.7.4586.
9
The mast cell and allergic diseases: role in pathogenesis and implications for therapy.
Clin Exp Allergy. 2008 Jan;38(1):4-18. doi: 10.1111/j.1365-2222.2007.02886.x. Epub 2007 Nov 21.
10
Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation.
Immunol Rev. 2007 Jun;217:168-85. doi: 10.1111/j.1600-065X.2007.00512.x.
Zotero 插件